SCHEMBL9535601

SCHEMBL9535601

O=c1c2c(c3cccnc3n1-c1cccc(Cl)c1)CCCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.50
MEN1 O00255 1/20 0.50
CYP1A2 P05177 1/20 0.50
HPGD P15428 1/20 0.50
CYP2C19 P33261 1/20 0.50
KMT2A Q03164 1/20 0.50
EPHB4 P54760 1/20 0.43
ALDH1A1 P00352 3/20 0.43
PDE4A P27815 4/20 0.41
KDM4E B2RXH2 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PDE4B Q07343 3/20 0.41
PDE4D Q08499 3/20 0.41
GAA P10253 1/20 0.40
FEN1 P39748 1/20 0.40
PDE4C Q08493 2/20 0.40
ALOX5 P09917 1/20 0.39
TP53 P04637 1/20 0.39
MAPK1 P28482 1/20 0.39
DDB1 Q16531 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9535305 0.85 FEN1 (0.55) CYP2C19EPHB4ALDH1A1PDE4AKDM4E
SCHEMBL9628920 0.85 MAPT (0.46) MAPTMEN1CYP1A2HPGDCYP2C19
SCHEMBL6009928 0.84 MAPT (0.49) MAPTMEN1CYP1A2HPGDCYP2C19
SCHEMBL30438257 0.84 MAPT (0.49) MAPTMEN1CYP1A2HPGDCYP2C19
SCHEMBL10377111 0.84 MAPT (0.47) MAPTMEN1CYP1A2HPGDCYP2C19
SCHEMBL9532938 0.83 FEN1 (0.55) MAPTCYP2C19ALDH1A1PDE4AKDM4E
SCHEMBL9799534 0.82 MAPT (0.50) MAPTMEN1CYP1A2HPGDCYP2C19
SCHEMBL9799505 0.82 MEN1 (0.47) MAPTMEN1CYP1A2HPGDCYP2C19
SCHEMBL10379090 0.81 MAPT (0.46) MAPTMEN1CYP1A2HPGDCYP2C19
SCHEMBL9629146 0.81 MAPT (0.49) MAPTMEN1CYP1A2HPGDCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0241291-B1 ARYL-SUBSTITUTED NAPHTHYRIDINE AND PYRIDOPYRAZINE DERIVATIVES SCHERING CORPORATION (US) 1993-06-02 EP claimed
EP-0241291-A2 Aryl-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1987-10-14 EP claimed
US-5045542-A Immune suppression method employing aryl-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1991-09-03 US disclosed
US-5011860-A Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases SCHERING CORPORATION (US) 1991-04-30 US disclosed
US-4882332-A Immune suppression method employing arly-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1989-11-21 US disclosed
US-4866061-A TREATMENT OF ALLERGIC REACTIONS, ULCERS, INFLAMMATION SCHERING CORPORATION (US) 1989-09-12 US disclosed
US-4760073-A Aryl-substituted naphthyridine and pyridopyrazine derivatives, useful as anti-allergic agents SCHERING CORPORATION (US) 1988-07-26 US disclosed
EP-0241291-A2 Aryl-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1987-10-14 EP disclosed